Edit Csada

Medicine · Health Sciences

8h-index498citations17works3.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Diagnosis and Treatment(8), Lung Cancer Treatments and Mutations(8), Cancer Treatment and Pharmacology(4), Colorectal Cancer Treatments and Studies(3), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(2)

Publications17 total

Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources
Pathology & Oncology Research·2024· 3 citedOpen Access
Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
Frontiers in Oncology·2023· 8 citedOpen Access
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers
Molecular & Cellular Proteomics·2023· 5 citedOpen Access
Architectural Grade Combined With Spread Through Air Spaces (STAS) Predicts Recurrence and is Suitable for Stratifying Patients Who Might Be Eligible for Lung Sparing Surgery for Stage I Adenocarcinomas
Pathology & Oncology Research·2020· 15 citedOpen Access
The efficacy and safety of bevacizumab in addition to platinum‑based chemotherapy for the first‑line treatment of patients with advanced nonsquamous non‑small‑cell lung cancer: Final results of AVALANCHE, an observational cohort study
Oncology Letters·2018· 3 citedOpen Access
Tüdőlebeny-eltávolítást követő kemoterápia tolerabilitását befolyásoló perioperatív tényezők
Orvosi Hetilap·2018· 1 cited
The more the micropapillary pattern in stage I lung adenocarcinoma, the worse the prognosis—a retrospective study on digitalized slides
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2018· 21 citedOpen Access
A műtétileg kezelt tüdőrák klinikopatológiai jellemzőinek változása az ezredfordulónkon
Orvosi Hetilap·2018
A műtétileg kezelt tüdőrák klinikopatológiai jellemzőinek változása az ezredfordulónkon = Changes in the clinicopathological features of surgically treated lung cancer around the millennium
2018· 1 cited
Tüdőlebeny-eltávolítást követő kemoterápia tolerabilitását befolyásoló perioperatív tényezők = Perioperative factors influencing the tolerability of chemotherapy after lung lobe resection
2018
Pulmonary epithelioid haemangioendothelioma studies in vitro and in vivo: new diagnostic and treatment methods.
PubMed·2013· 9 cited
Primary pulmonary epitheloid haemangioendothelioma
Orvosi Hetilap·2011· 1 cited
Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
Journal of Clinical Oncology·2007· 292 cited
A phase II trial of ZD6474 plus docetaxel in patients with previously treated NSCLC: Follow-up results
Journal of Clinical Oncology·2006· 73 cited
O-100 ZD6474 plus docetaxel in patients with previously treatedNSCLC: Results of a randomized, placebo-controlled Phase II trial
Lung Cancer·2005· 25 cited
A randomized, placebo-controlled phase II trial of ZD6474 plus docetaxel, in patients with NSCLC
Journal of Clinical Oncology·2005· 41 cited
Experience with Docetaxel in NSCC
Lung Cancer·1999

Frequent Co-authors

László Tiszlavicz(6), József Furák(5), John V. Heymach(4), Diane Prager(4), Jaromı́r Roubec(4), Regina Pálföldi(4), Roy S. Herbst(3), Tibor Géczi(3), Aurél Ottlakán(3), Balázs Pécsy(3), Attila Somfay(3), Gabriella Gálffy(3), Krisztina Bogos(3), Bruce E. Johnson(2), Miloš Pešek(2), Irena Špásová(2), Jeannie Hou(2), Jacqui Rowbottom(2), P. Fidias(2), Isaiah W. Dimery(2)